Efficacy and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Multiple Comorbidities

被引：0
作者：
Glaspole, I. [1 ,2 ]
Bonella, F. [3 ]
Bargagli, E. [4 ]
Glassberg, M. K. [5 ]
Caro, F. [6 ]
Stansen, W. [7 ]
Quaresma, M. [8 ]
Orsatti, L. [8 ]
Bendstrup, E. [9 ]
机构：
[1] Alfred Hlth, Dept Allergy Immunol & Resp Med, Melbourne, Vic, Australia
[2] Monash Univ, Dept Med, Melbourne, Vic, Australia
[3] Duisburg Essen Univ, Interstitial & Rare Lung Dis Unit, Ruhrlandklin, Univ Hosp, Essen, Germany
[4] Siena Univ Hosp, Sect Resp Dis & Lung Transplantat, Dept Clin Med & Neurosci, Siena, Italy
[5] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
[6] Maria Ferrer Hosp, Buenos Aires, DF, Argentina
[7] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany
[8] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[9] Aarhus Univ Hosp, Dept Resp Dis & Allergy, Aarhus, Denmark
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2020年 / 201卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4549
引用
收藏
页数：2
相关论文
共 50 条
[41]   Safety, tolerability and appropriate use of nintedanib in idiopathic pulmonary fibrosis [J].
Corte, Tamera ;
Bonella, Francesco ;
Crestani, Bruno ;
Demedts, Maurits G. ;
Richeldi, Luca ;
Coeck, Carl ;
Pelling, Katy ;
Quaresma, Manuel ;
Lasky, Joseph A. .
RESPIRATORY RESEARCH, 2015, 16
[42]   Efficacy of nintedanib in a patient with acute exacerbation of idiopathic pulmonary fibrosis [J].
Lv, Chengna ;
Guo, Lun ;
Tang, Pan ;
Deng, Zaichun ;
Ding, Qunli .
BRITISH JOURNAL OF HOSPITAL MEDICINE, 2022, 83 (03)
[43]   Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis [J].
Kolb, Martin ;
Raghu, Ganesh ;
Wells, Athol U. ;
Behr, Juergen ;
Richeldi, Luca ;
Schinzel, Birgit ;
Quaresma, Manuel ;
Stowasser, Susanne ;
Martinez, Fernando J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (18) :1722-1731
[44]   Nintedanib Treatment for Elderly Patients with Idiopathic Pulmonary Fibrosis [J].
Ochi, Y. ;
Kato, M. ;
Sasaki, S. ;
Nakamura, T. ;
Yamada, T. ;
Ihara, H. ;
Takahashi, F. ;
Takahashi, K. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
[45]   Safety and efficacy of nintedanib in idiopathic pulmonary fibrosis: A real-life observational study in Greece [J].
Tzouvelekis, Argyrios ;
Karampitsakos, Theodoros ;
Kontou, Maria ;
Granitsas, Andreas ;
Malliou, Ioanna ;
Anagnostopoulos, Aris ;
Ntolios, Paschalis ;
Tzilas, Vasilios ;
Bouros, Evangelos ;
Steiropoulos, Paschalis ;
Chrysikos, Serafeim ;
Dimakou, Katerina ;
Koulouris, Nikolaos ;
Bouros, Demosthenes .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2018, 49 :61-66
[46]   Population pharmacokinetics of nintedanib in patients with idiopathic pulmonary fibrosis [J].
Schmid, Ulrike ;
Doege, Christiane ;
Dallinger, Claudia ;
Freiwald, Matthias .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 :136-143
[47]   Effect of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis Reply [J].
Costabel, Ulrich ;
Stansen, Wibke ;
Stowasser, Susanne .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195 (09) :1275-1275
[48]   Real-world safety profiles of pirfenidone and nintedanib in idiopathic pulmonary fibrosis patients [J].
Fournier, D. ;
Jouneau, S. ;
Bouzille, G. ;
Polard, E. ;
Osmont, M. N. ;
Scailteux, L. M. .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 :77-78
[49]   Idiopathic pulmonary fibrosis treated by Nintedanib: evaluation of safety even in patients treated with anticoagulants [J].
Ruaro, Barbara ;
Pozzan, Riccardo ;
Confalonieri, Paola ;
Kodric, Metka ;
Cifaldi, Rossella ;
Barbieri, Mariangela ;
Lerda, Selene ;
Confalonieri, Marco ;
Baratella, Elisa ;
Salton, Francesco .
EUROPEAN RESPIRATORY JOURNAL, 2023, 62
[50]   Real-world safety profiles of pirfenidone and nintedanib in idiopathic pulmonary fibrosis patients [J].
Fournier, Dorine ;
Jouneau, Stephane ;
Bouzille, Guillaume ;
Polard, Elisabeth ;
Osmont, Marie-Noëlle ;
Scailteux, Lucie-Marie .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2022, 76
12345